March 26 (Reuters) - Gene therapy maker bluebird bio said on Tuesday it plans to restate its financial statements for 2022 and for each of the first three quarters of 2022 and 2023 following accounting errors. The company has also identified material weakness in its internal control over financial reporting, it said. The errors related to accounting of certain arrangements...

07:09 AM EDT, 03/26/2024 (MT Newswires) -- Alibaba Group Holding ( BABA ) said Tuesday its subsidiary Cainiao Smart Logistics Network has withdrawn its initial public offering and listing application on the Hong Kong Stock Exchange. Alibaba ( BABA ) said it plans to offer minority shareholders of Cainiao an opportunity to sell their stakes to Alibaba Group ( BABA...

GENEVA (Reuters) -China has initiated dispute settlement proceedings against the United States at the World Trade Organization (WTO) to safeguard its interests in the electric vehicle industry, the Chinese permanent mission to the WTO said on Tuesday. China said it was contesting discriminatory subsidies in nature under the U.S. Inflation Reduction Act it said resulted in the exclusion of goods...

(Reuters) -Viking Therapeutics said on Tuesday its experimental tablet helped reduce weight and was shown to be safe in an early-stage study, sending the company's shares 10% higher in premarket trading. The company said it plans to initiate a phase 2 trial later this year, based on the early-stage data. Viking Therapeutics said a mean weight loss of up to...